Lv3
350 积分 2022-11-10 加入
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
2天前
已完结
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents
10天前
已完结
Abrocitinib efficacy and safety in patients with moderate‐to‐severe atopic dermatitis: Results from phase 3 studies, including the long‐term extension JADE EXTEND study
1个月前
已完结
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus
1个月前
已完结
Efficacy and safety of cadonilimab, an anti-PD-1/CTLA4 bi-specific antibody, in previously treated recurrent or metastatic (R/M) cervical cancer: a multicenter, open-label, single-arm, phase II trial (075)
3个月前
已完结
Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
4个月前
已完结
Inhibiting Janus kinases to treat alopecia areata
4个月前
已完结
Alopecia Areata
4个月前
已完结
Prevalence of Alopecia Areata in the First National Health and Nutrition Examination Survey
4个月前
已完结
Alopecia areata update
4个月前
已完结
皖公网安备34019202002308
